In the BioHarmony Drug Report Database

"Preview" Icon

Fluorouracil

Adrucil, Carac, Efudex, Fluoroplex, Fluorouracil, Tolak (fluorouracil) is a small molecule pharmaceutical. Fluorouracil was first approved as Adrucil on 1982-01-01. It is used to treat basal cell carcinoma, breast neoplasms, colonic neoplasms, head and neck neoplasms, and keratosis amongst others in the USA. Efudex’s patents are valid until 2023-07-18 (FDA).

 

Trade Name

 

Adrucil, Carac, Efudex, Fluoroplex, Fluorouracil, Tolak
 

Common Name

 

fluorouracil
 

ChEMBL ID

 

CHEMBL185
 

Indication

 

basal cell carcinoma, breast neoplasms, colonic neoplasms, head and neck neoplasms, keratosis, pancreatic neoplasms, rectal neoplasms, stomach neoplasms
 

Drug Class

 

Uracil type antineoplastics; uracil derivatives used as thyroid antagonists and as antineoplastics

Image (chem structure or protein)

Fluorouracil structure rendering